Research Paper Volume 15, Issue 3 pp 689—704
The pan-cancer analysis identified DIAPH3 as a diagnostic biomarker of clinical cancer
Figure 10. Expression of Diaphanous Related Formin 3 (DIAPH3) in cancer and normal tissues. (A) Western blot to verify the expression of DIAPH3 in cancer and normal cervical tissues (the experiment was repeated thrice). (B) Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) to verify the expression of DIAPH3 in cancer and normal cervical tissues (the experiment was repeated four times). (C) The expression of DIAPH3 in cancer tissue verified by immunohistochemistry. (D) The expression of DIAPH3 in normal cervical tissue verified by immunohistochemistry. *p < 0.001.